A 2-pyridone compound represented by the formula [1]:
wherein in the formula [1],
the ring represented by A represents a benzene ring or a pyridine ring,
X represents any of the structures represented by the formulas [3] shown below:
V represents a single bond or a lower alkylene group, and
W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)},
a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.
A 2-pyridone compound represented by the formula [1]:
wherein in the formula [1],
the ring represented by A represents a benzene ring or a pyridine ring,
X represents any of the structures represented by the formulas [3] shown below:
V represents a single bond or a lower alkylene group, and
W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)},
a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.